Barclays CEO diagnosed with non-Hodgkin lymphoma
By Iain Gilbert
Date: Monday 28 Nov 2022
(Sharecast News) - Banking giant Barclays said on Monday that chief executive CS Venkatakrishnan will be undergoing treatment for non-Hodgkin lymphoma.
Barclays stated Venkatakrishnan will undergo treatment at Memorial Sloan Kettering Cancer Center in New York, with his condition labelled as being curable with the hospital's prescribed regimen.
However, he said he will have to work from home "for some periods" and not be able to travel.
"The board has been kept apprised of my situation and I am enormously grateful for their support," said Venkatakrishnan.
"We have a highly capable and seasoned executive committee, supported by a talented senior management team. I am very confident that we will continue, with your help, to serve our customers and clients well, and produce strong operating performance for our shareholders."
As of 1020 GMT, Barclays shares were up 0.50% at 159.86p.
Reporting by Iain Gilbert at Sharecast.com
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN